Skip to main content

Elizabeth Gianini, Greg Roth, Bjorn Par Tyrberg, Mike Dollar, Adele Cirone Oliva

Burnham Institute for Medical Research has named Elizabeth Gianini as vice president, external relations for Burnham’s Orlando, Fla.-based offices.
Gianini will join Burnham on July 9 from her current position as chief of staff to Mayor Richard Crotty. Prior to her position with the County of Orlando, Gianini held appointments as director of public affairs for Foley and Lardner in Washington, DC; deputy chief of staff and assistant US trade representative in the office of the US Trade Ambassador; deputy executive director for the Republican party of Florida, Tallahassee; and district director for Congressman Bill McCollum in Orlando.
Separately, Burnham announced the appointment of three new staffers to its Orlando offices:
Greg Roth was named director of medicinal chemistry. Most recently, Roth served as associate director of medicinal chemistry at Abbott Bioresearch Center in Worcester, Mass. He is also an adjunct professor at Boston University’s department of chemistry and center for methodology and library development. Roth holds a PhD in chemistry from Colorado State University.
Bjorn Par Tyrberg was appointed as assistant professor for Burnham. Tyrberg holds a PhD in medical sciences from Uppsala University in Sweden, and recently completed postdoctoral work with diabetes researcher Fred Levine at the University of California, San Diego.
Mike Dollar was named vice president of finance and chief financial officer for Burnham. He joined Burnham in July 2004 as controller from the Sidney Kimmel Cancer Center in La Jolla, Calif., where he worked as director of finance. He also worked for several years with Deloitte and Touche.

Quaker Bioventures last week said that Adele Cirone Oliva will join the firm as its newest partner in June. Oliva will be responsible for helping to execute Quaker’s investment strategy to catalyze venture investment in the underserved life sciences industry in the Mid-Atlantic market.
Oliva joins Quaker from Apex Partners in New York, where she was co-head of the firm’s US health care group.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.